When was Imaginostics founded?

Imaginostics was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is Imaginostics located?

Imaginostics is headquartered in Cambridge, United States.

Who is the current CEO of Imaginostics?

Codi Amir Gharagouzloo of Imaginostics. They have also founded 1 company.

How many employees does Imaginostics have?

As of Aug 31, 2026, the latest employee count at Imaginostics is 5.

Is Imaginostics a funded company?

Imaginostics is a funded company, having raised a total of $7.64M across 11 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 21, 2018.

When was the latest funding round of Imaginostics?

Imaginostics' latest funding was a $***** Series A round on May 14, 2026, with participation from 0 investor. Its primary sector is Clinical Labs IT. In United States, the Clinical Labs IT sector has seen $474M in funding in 2026 to date.

Where does Imaginostics rank among its competitors?

Imaginostics ranks 40th amongst 782 active competitors, of which 153 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Imaginostics, which secured $40K in May, 2026.

Who are the top competitors of Imaginostics?

Imaginostics' top competitors include HeartFlow, Oxipit and ScreenPoint. Among them, Imaginostics secured the most recent funding round in May, 2026.

Imaginostics - 2026 Company Profile, Team, Funding & Competitors

Imaginostics is a series A company based in Cambridge (United States), founded in 2011 by Codi Amir Gharagouzloo. It operates as a Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder. Imaginostics has raised $7.64M in funding from Ideaship. The company has 782 active competitors, including 153 funded and 45 that have exited. Its top competitors include companies like HeartFlow, Oxipit and ScreenPoint.

Company Details

Imaginostics provides the solution for magnetic resonance imaging (MRI) biomarkers for the diagnosis of neurological disorders like Alzheimer’s Disease and Dementias. It offers its proprietary software solution for non-invasive early diagnostics. The technology detects the biomarker of Cance, Cardiovascular, Kidney, and Alzheimer’s Disease and Related Dementias. The platform can be integrated with the existing MRI scanners and hardware of users for data visualization.

Key Metrics

Founded Year

2011

Location

Cambridge, United States

Stage

Series A

Total Funding

$7.64M in 11 rounds

Latest Funding Round

Series A, May 14, 2026, $*****

Investors

Ideaship & 3 more

Ranked

40^th among 782 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Oxipit & 729 more

View Imaginostics' full profile

Imaginostics has raised a total funding of $7.64M over 11 rounds. Its first funding round was on Jul 21, 2018. Imaginostics has 4 institutional investors.

Here is the list of recent funding rounds of Imaginostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 14, 2026	3217714	Series A	5600470	3867699	3356785	8546122
Aug 06, 2025	6648080	Grant (prize money)	7000188	1981876	6043605	HHS
Feb 03, 2024	8495427	Series A	6260410	7087143	3262730	9873422

Access funding benchmarks and valuations. Sign up today!

View details of Imaginostics's funding rounds and investors

The founders of Imaginostics is Codi Amir Gharagouzloo. Codi Amir Gharagouzloo is the CEO of Imaginostics.

Here are the details of Imaginostics' key team members:

Codi Amir Gharagouzloo: Founder & CEO of Imaginostics.
Contact Info: 1 email address

View details of Imaginostics's Founder profiles and Board Members

Imaginostics' employee count trend

Imaginostics has 5 employees as of Aug 26. Here is Imaginostics's employee count trend over the years:

Uncover Imaginostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Imaginostics include HeartFlow, Oxipit and ScreenPoint. Here is the list of Top 10 competitors of Imaginostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HeartFlow 2007, Redwood City (United States), Public	Provides cardiovascular diagnostic support using analytics	$936M	Bain Capital Life Sciences, Baillie Gifford ... & 24 others	70/100
2nd	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Practica Capital, CoInvest Capital & 4 others	66/100
3rd	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Siemens, Insight Partners & 3 others	64/100
4th	Optellum 2015, Oxford (United Kingdom), Series A	Provider of AI-based cancer diagnostics platform	$20.6M	IQ Capital, Luminous Ventures & 35 others	63/100
5th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Open Field Capital, Khosla Ventures & 12 others	62/100
6th	IXICO 2004, London (United Kingdom), Public	AI-based medical image management and analysis solutions for healthcare organizations	-	Leonne International, IP Group & 3 others	62/100
7th	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	ES Investor, SBI Investment Korea & 19 others	61/100
8th	Us2.ai 2017, Singapore (Singapore), Series A	AI-powered tool for the detection of heart risk	$19.1M	EDBI, IHH Healthcare Berhad & 15 others	61/100
9th	Olea Medical 2008, La Ciotat (France), Acquired	Developer of medical diagnostic software solutions for image post-processing	$6.7M	Innovacom, Turenne Groupe & 2 others	61/100
10th	Sirona Medical 2018, San Francisco (United States), Series C	AI-powered cloud-native radiology workflow management software	$99.7M	Avidity Partners, GreatPoint Ventures & 6 others	61/100
40th	Imaginostics 2011, Cambridge (United States), Series A	Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder	$7.64M	Ideaship, HHS & 2 others	51/100